CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Telmisartan / Amlodipine

Last Updated: July 9, 2010
Result type: Reports
Project Number: S0207
Product Line: Reimbursement Review

Generic Name: Telmisartan / Amlodipine

Brand Name: Twynsta

Manufacturer: Boehringer Ingelheim (Canada) Ltd

Indications: Hypertension, Essential

Submission Type: Pre-NOC

Project Status: Cancelled